| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.5B | $5.2B | $5.8B | $5.8B | $5.3B | $4.1B | $5.4B | $5.7B |
| Cost of Revenue | $2.7B | $3.0B | $3.3B | $3.4B | $3.2B | $2.4B | $3.2B | $3.4B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B |
| SG&A Expense | $1.1B | $1.1B | $1.2B | $1.1B | $1.0B | $1.1B | $1.2B | $1.3B |
| Operating Income | $0.4B | $0.4B | $0.8B | $0.9B | $0.8B | $0.0B | $0.6B | $0.7B |
| Net Income | $0.3B | $0.5B | $0.7B | $0.7B | $0.7B | $0.0B | $0.4B | $0.5B |
| EPS (Basic) | $2.82 | $3.46 | $4.96 | $5.01 | $4.23 | $0.01 | $0.09 | $3.21 |
| EPS (Diluted) | $2.78 | $3.44 | $4.87 | $4.96 | $4.19 | $0.01 | $0.09 | $3.19 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $8.0B | $11.9B | $12.1B | $11.5B | $11.1B | $12.0B | $10.5B | $10.7B |
| Current Assets | $5.6B | $5.0B | $5.2B | $4.8B | $4.6B | $5.8B | $4.2B | $4.5B |
| Cash & Equivalents | $3.1B | $1.6B | $1.5B | $1.4B | $1.9B | $3.3B | $0.8B | $1.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $2.7B | $3.6B | $3.4B | $3.5B | $3.3B | $4.0B | $3.2B | $3.6B |
| Stockholders' Equity | $3.1B | $3.2B | $3.3B | $2.9B | $2.6B | $1.7B | $1.8B | $1.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $1.1B | $0.8B | $0.5B | $1.0B | $1.2B | $0.9B | $1.2B |
| Investing Cash Flow | $3.8B | $-0.4B | $-0.5B | $-0.8B | $-0.5B | $-0.1B | $-0.5B | $-0.7B |
| Capital Expenditures | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.2B | $0.2B |
| Financing Cash Flow | $-3.0B | $-0.6B | $-0.2B | $-0.2B | $-1.9B | $1.4B | $-0.7B | $-0.0B |